Table 4C.
Change in MacTSQ subscales between M1 (MacTSQ baseline) to M6, 12 and 18 in the subset of participants in whom at baseline the study eye was the ‘worse’ eye compared with the fellow eye in terms of BCVA letters
Change in MacTSQ subscales | Mean 1 | Mean 2 | Difference | 95% CI | Significance |
Subscale 1: information provision and convenience | |||||
Pair 1 (n=69) Months 1–6 |
32.86 | 33.72 | 0.87 | 0.18 to 1.56 | 0.015 |
Pair 2 (n=70) Subscale 1 Months 1–12 |
33.31 | 34.20 | 0.89 | 0.29 to 1.48 | 0.004 |
Pair 3 (n=67) Months 1–18 |
33.24 | 34.04 | 0.81 | 0.08 to 1.54 | 0.031 |
Subscale 2: impact of treatment and treatment satisfaction | |||||
Pair 4 (n=70) Months 1–6 |
28.87 | 31.20 | 2.59 | 1.56 to 3.62 | <0.001 |
Pair 5 (n=70) Months 1–12 |
29.57 | 32.34 | 3.47 | 2.46 to 4.48 | <0.001 |
Pair 6 (n=67) Months 1–18 |
28.73 | 32.67 | 3.94 | 2.81 to 5.10 | <0.001 |
BCVA, best-corrected visual acuity; MacTSQ, Macular Disease Society Treatment Satisfaction Questionnaire.